Pilot Study for Automated Deep Brain Stimulation Programming
DBS-Expert: Automated Deep Brain Stimulation Programming Using Functional Mapping - Phase I
Sponsor: Great Lakes NeuroTechnologies Inc.
Listed as NCT02046863, this NA trial focuses on Bradykinesia and Parkinson's Disease and remains completed. Sponsored by Great Lakes NeuroTechnologies Inc., it has been updated 8 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Feb 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Great Lakes NeuroTechnologies Inc.
- National Institute of Neurological Disorders and Stroke (NINDS)
- University of Cincinnati
For direct contact, visit the study record on ClinicalTrials.gov .